Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bucher

Showing results (61-70 of 406) with videos related to

Pageof 41
Sort By:
Sexually Transmitted Infections|September 3, 2025
Effectiveness of the national HIV pre-exposure prophylaxis (PrEP) programme among female sex workers in Rwanda: a retrospective cohort studyEric Remera, Sabin Nsanzimana, Frédérique Chammartin, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996
Incidence of disseminated histoplasmosis in HIV-infected patients in SwitzerlandH C Bucher, K Gyr, B Ledergerber, et al.
Annals of Internal Medicine|January 24, 1998
Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trialsH C Bucher, L E Griffith, G H Guyatt
International Journal of STD & AIDS|July 22, 1999
A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort StudyM Opravil, B Hirschel, H C Bucher, et al.
The New England Journal of Medicine|March 10, 2009
Rosuvastatin in patients with elevated C-reactive proteinMichael T Koller, Heiner C Bucher, Ewout W Steyerberg
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Cost-effectiveness of drug-eluting stents in a US Medicare setting:a cost-utility analysis with 3-year clinical follow-up dataMatthias Bischof, Matthias Briel, Heiner C Bucher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Reasons for discontinuation of first highly active antiretroviral therapy in a cohort of proteinase inhibitor-naive HIV-infected patientsA Hänsel, H C Bucher, R Nüesch, et al.
Evidence-Based Child Health : a Cochrane Review Journal|September 18, 2013
Response by authorsPhilipp Schuetz, Matthias Briel, Heiner C Bucher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Systematic review on the risk and benefit of different cholesterol-lowering interventionsH C Bucher, L E Griffith, G H Guyatt
Military Medicine|July 1, 1970
Occult thyroid carcinoma and the cold noduleR W Clark, W C Bucher, M L Nusynowitz
Pageof 41

Showing results (61-70 of 406) with videos related to

Sort By:
Pageof 41
Sexually Transmitted Infections|September 3, 2025
Effectiveness of the national HIV pre-exposure prophylaxis (PrEP) programme among female sex workers in Rwanda: a retrospective cohort studyEric Remera, Sabin Nsanzimana, Frédérique Chammartin, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996
Incidence of disseminated histoplasmosis in HIV-infected patients in SwitzerlandH C Bucher, K Gyr, B Ledergerber, et al.
Annals of Internal Medicine|January 24, 1998
Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trialsH C Bucher, L E Griffith, G H Guyatt
International Journal of STD & AIDS|July 22, 1999
A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort StudyM Opravil, B Hirschel, H C Bucher, et al.
The New England Journal of Medicine|March 10, 2009
Rosuvastatin in patients with elevated C-reactive proteinMichael T Koller, Heiner C Bucher, Ewout W Steyerberg
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Cost-effectiveness of drug-eluting stents in a US Medicare setting:a cost-utility analysis with 3-year clinical follow-up dataMatthias Bischof, Matthias Briel, Heiner C Bucher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Reasons for discontinuation of first highly active antiretroviral therapy in a cohort of proteinase inhibitor-naive HIV-infected patientsA Hänsel, H C Bucher, R Nüesch, et al.
Evidence-Based Child Health : a Cochrane Review Journal|September 18, 2013
Response by authorsPhilipp Schuetz, Matthias Briel, Heiner C Bucher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Systematic review on the risk and benefit of different cholesterol-lowering interventionsH C Bucher, L E Griffith, G H Guyatt
Military Medicine|July 1, 1970
Occult thyroid carcinoma and the cold noduleR W Clark, W C Bucher, M L Nusynowitz
Pageof 41